Status:
COMPLETED
Prognostic Value of the 6-minute Stepper Test in Non-small Cell Lung Cancer Surgery
Lead Sponsor:
University Hospital, Rouen
Conditions:
Lung Neoplasm Malignant
Resectable Lung Non-Small Cell Carcinoma
Eligibility:
All Genders
18+ years
Brief Summary
The objective of this study is to evaluate the performances of the Six-Minute Stepper Test (6MST) and Sit To Stand test (STST) to predict post-operative complications after minimally invasive lung can...
Eligibility Criteria
Inclusion
- Age \>18
- Non-small cell lung cancer stage I to II, justifying major resection by VATS or RATS (segmentectomy, lobectomy, pneumonectomy), with or without histological confirmation
Exclusion
- Partial or total amputation localized to the lower limb;
- Weight greater than 100 kg;
- Orthopedic, vascular or neurological disorders leading to the incapacity of realize the 6MST;
- Patient under tutorship or curatorship;
- Pregnant woman.
- Surgery canceled
Key Trial Info
Start Date :
November 21 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 4 2020
Estimated Enrollment :
122 Patients enrolled
Trial Details
Trial ID
NCT03824977
Start Date
November 21 2018
End Date
February 4 2020
Last Update
March 7 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Boujibar , F
Rouen, France